Our findings suggest the need for targeted risk assessment tools to predict the highest-risk patients for poor retention whereby public health interventions can be directed to those individuals.
No takes yet. Share an insight, caveat, or question.
Colasanti et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from JAIDS Journal of Acquired Immune Deficiency Syndromes